Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 41-50 of 84

Page
per page
  1. Valdecoxib
    B1459 Valdecoxib
    Target: COX
    Summary: COX-2 inhibitor
      insoluble in H2O; ≥15.72 mg/mL
  2. Mizoribine
    B1472 Mizoribine
    Target: Synthases/Synthetases
    Summary: DNA/RNA synthesis inhibitor
      insoluble in EtOH; ≥88.2 mg/mL
  3. Pizotifen Malate
    B2007 Pizotifen Malate
    Target: 5-HT2 Receptors|D2 Receptors
    Summary: 5-HT receptor antagonist
      ≥21.48 mg/mL
  4. Cefoselis Sulfate
    B1906 Cefoselis Sulfate
    Target: Peptidoglycan synthesis
    Summary: beta-lactam antibiotic
      ≥62.1 mg/mL
  5. Azaguanine-8
    B1667 Azaguanine-8
    Summary: Purine analogs
      insoluble in H2O; insoluble in EtOH; ≥3.93 mg/mL
  6. Cyclizine 2HCl
    B1548 Cyclizine 2HCl
    Target: Histamine H1 Receptors
    Summary: Histamine H1 receptor antagonist
      Soluble in DMSO
  7. Mechlorethamine HCl
    B1785 Mechlorethamine HCl
    Summary: DNA synthesis inhibitor
  8. Niclosamide
    B2283 Niclosamide
    Target: STAT
    Summary: Inhibitor of the STAT3 signaling pathway
  9. Reboxetine mesylate
    B2124 Reboxetine mesylate
    Target: Noradrenaline reuptake
    Summary: Potent and selective inhibitor of noradrenalin uptake
      ≥41 mg/mL
  10. Tolbutamide
    B2194 Tolbutamide
    Target: cAMP|Sulfonylurea receptors
    Summary: first generation potassium channel blocker
      insoluble in H2O; ≥10.05 mg/mL

Items 41-50 of 84

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 75item
  2. Natural Products 2item
  3. Kits 1 item
  4. Lab Reagents 2item
Reversibility
  1. Reversible 4item
  2. Irreversible 2item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 4item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 4item
  5. PI3K 4item
  6. Raf 3item
  7. CSF-1R 1 item
  8. Peptidylprolyl isomerases 1 item
  9. FLT3 2item
  10. GSK-3 2item
  11. Factor Xa 1 item
  12. VEGFR 4item
  13. PDGFR 4item
  14. c-Kit 2item
  15. RET 1 item
  16. p38 2item
  17. FGFR 1 item
  18. Deubiquitinating enzymes (DUBs) 2item
  19. PP1 1 item
  20. PP2A 1 item
  21. MET 2item
  22. Trk Receptors 1 item
  23. STAT 1 item
  24. Topoisomerases 1 item
  25. Cytochrome P450 (CYP450) 1 item
  26. HMG-CoA Reductases 1 item
  27. c-MET 3item
  28. 5-HT2 Receptors 1 item
  29. DGAT 1 item
  30. Insulin and Insulin-like Receptors 1 item
  31. PARP 1 item
  32. ALK 1 item
  33. Myosin light chain kinases (MLCKs) 1 item
  34. D2 Receptors 1 item
  35. Angiotensin-Converting Enzymes (ACEs) 1 item
  36. Autophagy 1 item
  37. COX 1 item
  38. Pregnane X Receptors 1 item
  39. GpIIb/IIIa receptor 1 item
  40. Peroxynitrite 1 item
  41. Ron 1 item
  42. Synthases/Synthetases 1 item
  43. Histamine H1 Receptors 1 item
  44. Phospholipases 1 item
  45. IL Receptors 1 item
  46. CCL2 1 item
  47. Noradrenaline reuptake 1 item
  48. cAMP 1 item
  49. Sulfonylurea receptors 1 item
  50. Peptidoglycan synthesis 1 item
  51. Nuclear Receptors 1 item
  52. Catechol O-Methyltransferase (COMT) 1 item
  53. Angiotensin AT1 Receptors 1 item
  54. DREADD Ligands 1 item
  55. PP4 1 item
  56. Ub-conjugating enzyme (E2) complex 1 item
  57. PPAR 1 item
  58. IKK 1 item
  59. P97 ATPase 1 item
  60. ITK 1 item
  61. NUAK 1 item
  62. NOP Receptors 1 item
  63. PRMT 1 item
  64. Serotonin (5-HT) reuptake 1 item
  65. NE 1 item
  66. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. B-lymphoid Malignancies 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 8item
  7. Cancer 37item
  8. Chronic Lymphocytic Leukemia 2item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 4item
  11. Colorectal Cancer 7item
  12. Depression 1 item
  13. Diabetes 2item
  14. Glioblastoma 4item
  15. Glioma 2item
  16. Hepatocellular Carcinoma 1 item
  17. Inflammatory Diseases 2item
  18. Lung Cancer 1 item
  19. Lung Carcinoma 1 item
  20. Lymphoma 5item
  21. Mantle Cell Lymphoma 2item
  22. Melanoma 2item
  23. Multiple Myeloma 4item
  24. Myeloma 1 item
  25. Neuroblastoma 3item
  26. Neurocognitive Disorders 1 item
  27. Non-small Cell Lung Cancer 3item
  28. Obsessive-Compulsive Disorder 1 item
  29. Ovarian Cancer 3item
  30. Pancreatic Cancer 3item
  31. Prostate Cancer 3item
  32. Renal Cancer 1 item
  33. Rheumatoid Arthritis 1 item
  34. Schizophrenia 2item
  35. Thyroid Cancer 1 item
  36. Type 2 Diabetes 2item